End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.01 TWD | -0.12% | -1.72% | -15.33% |
04-17 | Eusol Biotech Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Eusol Biotech Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Hong Jen Chang
CEO | Chief Executive Officer | 68 | 04/10/09 |
Chun Yue Lin
DFI | Director of Finance/CFO | - | - |
Wan Ya Chang
BRD | Director/Board Member | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Shih Chang Hsu
BRD | Director/Board Member | 61 | - |
Hong Jen Chang
CEO | Chief Executive Officer | 68 | 04/10/09 |
Tsung Jen Yang
BRD | Director/Board Member | - | 14/06/18 |
Weng Foung Huang
BRD | Director/Board Member | - | 14/06/18 |
Hung Mo Li
BRD | Director/Board Member | - | 14/06/18 |
Wan Ya Chang
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 137,000,000 | 92,100,000 ( 67.23 %) | 0 | 67.23 % |
Company contact information
Eusol Biotech Co., Ltd.
6/F, No. 135, Section 3 Minsheng East Road
105 44, Taipei
+
http://www.eusol.com.twSector
1st Jan change | Capi. | |
---|---|---|
-15.33% | 34.16M | |
+32.09% | 694B | |
+29.39% | 593B | |
-1.34% | 371B | |
+20.34% | 331B | |
+7.39% | 290B | |
+14.25% | 239B | |
-3.03% | 209B | |
+10.02% | 209B | |
+8.49% | 169B |
- Stock Market
- Equities
- 6652 Stock
- Company Eusol Biotech Co.,Ltd.